Literature DB >> 24789663

Evaluation of poly(2-ethyl-2-oxazoline) containing copolymer networks of varied composition as sustained metoprolol tartrate delivery systems.

Bistra Kostova1, Sijka Ivanova, Konstantin Balashev, Dimitar Rachev, Darinka Christova.   

Abstract

Segmented copolymer networks (SCN) based on poly(2-ethyl-2-oxazoline) and containing 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate, and/or methyl methacrylate segments have been evaluated as potential sustained release systems of the water soluble cardioselective β-blocker metoprolol tartrate. The structure and properties of the drug carriers were investigated by differential scanning calorimetry, attenuated total reflectance Fourier transform infrared spectroscopy, scanning electron microscopy, and atomic force microscopy. Swelling kinetics of SCNs in various media was followed, and the conditions for effective MT loading were specified. MT-loaded SCNs with drug content up to 80 wt.% were produced. The release kinetics of metoprolol tartrate from the systems was studied and it was shown that the conetworks of different structure and composition are able to sustain the metoprolol tartrate release without additional excipients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789663      PMCID: PMC4113615          DOI: 10.1208/s12249-014-0120-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  15 in total

1.  Drug delivery systems: entering the mainstream.

Authors:  Theresa M Allen; Pieter R Cullis
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

2.  Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.

Authors:  Robert Luxenhofer; Anita Schulz; Caroline Roques; Shu Li; Tatiana K Bronich; Elena V Batrakova; Rainer Jordan; Alexander V Kabanov
Journal:  Biomaterials       Date:  2010-03-26       Impact factor: 12.479

3.  Synthesis and evaluation of triazole-linked poly(ε-caprolactone)-graft-poly(2-methyl-2-oxazoline) copolymers as potential drug carriers.

Authors:  Brieuc Guillerm; Vincent Darcos; Vincent Lapinte; Sophie Monge; Jean Coudane; Jean-Jacques Robin
Journal:  Chem Commun (Camb)       Date:  2012-02-07       Impact factor: 6.222

4.  Study of the potential of amphiphilic conetworks based on poly(2-ethyl-2-oxazoline) as new platforms for delivery of drugs with limited solubility.

Authors:  Bistra Kostova; Krasimira Ivanova-Mileva; Dimitar Rachev; Darinka Christova
Journal:  AAPS PharmSciTech       Date:  2013-01-17       Impact factor: 3.246

5.  Strategies for the synthesis of poly(2-oxazoline)-based hydrogels.

Authors:  Andrew M Kelly; Frank Wiesbrock
Journal:  Macromol Rapid Commun       Date:  2012-07-19       Impact factor: 5.734

6.  Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers.

Authors:  A Forster; J Hempenstall; T Rades
Journal:  J Pharm Pharmacol       Date:  2001-03       Impact factor: 3.765

7.  Poly(2-oxazoline)s as Smart Bioinspired Polymers.

Authors:  Helmut Schlaad; Christina Diehl; Anja Gress; Matthias Meyer; A Levent Demirel; Yusuf Nur; Annabelle Bertin
Journal:  Macromol Rapid Commun       Date:  2010-01-05       Impact factor: 5.734

Review 8.  Pegnology: a review of PEG-ylated systems.

Authors:  D Bhadra; S Bhadra; P Jain; N K Jain
Journal:  Pharmazie       Date:  2002-01       Impact factor: 1.267

9.  HPLC study on the stability of bendamustine hydrochloride immobilized onto polyphosphoesters.

Authors:  Ivanka Pencheva; Anita Bogomilova; Neli Koseva; Danka Obreshkova; Kolio Troev
Journal:  J Pharm Biomed Anal       Date:  2008-09-07       Impact factor: 3.935

Review 10.  Poly(2-oxazolines) in biological and biomedical application contexts.

Authors:  Nico Adams; Ulrich S Schubert
Journal:  Adv Drug Deliv Rev       Date:  2007-08-22       Impact factor: 15.470

View more
  1 in total

1.  Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections.

Authors:  Mohammad Zaidur Rahman Sabuj; Tim R Dargaville; Lisa Nissen; Nazrul Islam
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.